NASDAQ · BDRX
Biodexa Pharmaceuticals Plc
Healthcare · Biotechnology
$0.68
Up+$0.00 (+0.15%)
Updated Sep 26, 2026, 2:31 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.12M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.60 – $11.88
- Volume
- 169.24K
- Avg. volume
- 695.79K
Price performance
BDRX price history
1M range · 20 trading sessions · Daily adjusted prices
BDRX closed at $0.68 after 20 trading sessions, down 22.13% for the selected period.
- Last close
- $0.68
- Period change
- -22.13%
- Period low
- $0.66
- Period high
- $1.33
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $0.662 | $0.6889 | $0.6536 | $0.676 | 169.24K |
| Sep 24, 2026 | $0.67 | $0.6935 | $0.658 | $0.675 | 127.73K |
| Sep 23, 2026 | $0.6827 | $0.73 | $0.655 | $0.6894 | 374.48K |
| Sep 22, 2026 | $0.67 | $0.69 | $0.61 | $0.681 | 745.58K |
| Sep 21, 2026 | $0.7401 | $0.7419 | $0.62 | $0.6799 | 629.25K |
| Sep 18, 2026 | $0.7795 | $0.8325 | $0.71 | $0.73 | 585.12K |
| Sep 17, 2026 | $0.8701 | $0.9459 | $0.72 | $0.7999 | 1.55M |
| Sep 16, 2026 | $1.23 | $1.27 | $0.85 | $0.96 | 3.43M |
| Sep 15, 2026 | $1.29 | $1.43 | $1.13 | $1.33 | 54.69M |
| Sep 14, 2026 | $1.29 | $1.46 | $1.10 | $1.12 | 6.16M |
| Sep 11, 2026 | $0.88 | $1.5499 | $0.8342 | $1.30 | 142.44M |
| Sep 10, 2026 | $0.7998 | $0.845 | $0.61 | $0.6601 | 202.08K |
| Sep 9, 2026 | $0.8441 | $0.8441 | $0.79 | $0.8122 | 101.77K |
| Sep 8, 2026 | $0.82 | $0.8999 | $0.82 | $0.8308 | 95.25K |
| Sep 4, 2026 | $0.7838 | $0.86 | $0.7731 | $0.848 | 105.07K |
| Sep 3, 2026 | $0.771 | $0.7988 | $0.7623 | $0.7984 | 99.61K |
| Sep 2, 2026 | $0.758 | $0.80 | $0.7553 | $0.7849 | 58.77K |
| Sep 1, 2026 | $0.79 | $0.81 | $0.7802 | $0.7808 | 82.69K |
| Aug 31, 2026 | $0.8576 | $0.8576 | $0.78 | $0.8117 | 114.31K |
| Aug 28, 2026 | $0.87 | $0.88 | $0.8303 | $0.8681 | 110.16K |
Latest BDRX news
The latest Smart Investors Daily articles mentioning BDRX.
Stock researchResearch & News · SEC Filings
Loading stock research…
